Drug Shortage Report for SUBLINOX

Last updated on 2017-11-13 History
Report ID 24049
Drug Identification Number 02370433
Brand name SUBLINOX
Common or Proper name SUBLINOX
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) ZOLPIDEM TARTRATE
Strength(s) 10MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration SUBLINGUAL
Packaging size N/A
ATC code N05CF
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2017-10-21
Actual start date
Estimated end date 2017-11-03
Actual end date 2017-11-10
Shortage status Resolved
Updated date 2017-11-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2017-11-13 French Compare
v9 2017-11-13 English Compare
v8 2017-11-03 French Compare
v7 2017-11-03 English Compare
v6 2017-11-01 English Compare
v5 2017-10-31 French Compare
v4 2017-10-31 English Compare
v3 2017-10-22 English Compare
v2 2017-10-02 French Compare
v1 2017-10-02 English Compare

Showing 1 to 10 of 10